59th ASH Annual Meeting Wrap-up: Hotlanta Freezes Over
2017 ASH News Daily Editor-in-Chief Dr. Saad Usmani recaps the 2017 ASH annual meeting which took place in Atlanta.
Predicting Responses to Gemtuzumab Ozogamicin
Dr. Raetz looks at the use of gemtuzumab ozogamicin (CO) for the treatment of acute myeloid leukemia in adults and children.
Drs. Andrea Baines and Ann Farrell explain the process of obtaining an investigational agent outside of a clinical trial through expanded access programs.
November-December 2017Volume 14, Issue 6
A new Compendium providing updated clinical information to "Ask the Hematologist" articles published in The Hematologist from 2010 to 2015 is now available.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology